Notes: Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) (“SCH” and, after the Domestication and business combination as described below, “Clover Health”), a publicly traded special purpose acquisition company, announced today that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination (the “business combination”) with Clover Health Investments, Corp. (“Clover”). Approximately 99.5% of the votes cast at the meeting, representing approximately 65.0% of SCH’s outstanding shares, voted to approve the business combination. The business combination is expected to close on January 7, 2021, subject to the satisfaction of customary closing conditions. Prior to the consummation of the business combination, SCH will domesticate as a Delaware corporation (the “Domestication”), and in connection with the business combination, will change its name to “Clover Health Investments, Corp.” Trading is expected to begin on The Nasdaq Global Select Market on January 8, 2021, under the new ticker symbol “CLOV” for Clover Health Class A common stock and “CLOVW” for Clover Health warrants. Until the Domestication and transfer is complete, the SCH common stock, warrants and units will continue to trade under the ticker symbols “IPOC”, "IPOC.WS" and "IPOC.U", respectively, on NYSE.